{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:32:56Z","timestamp":1788489176248,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.msard.2020.102393","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T01:45:57Z","timestamp":1594518357000},"page":"102393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0607-904X","authenticated-orcid":false,"given":"Smathorn","family":"Thakolwiboon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-079X","authenticated-orcid":false,"given":"Hannah","family":"Zhao-Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amputch","family":"Karukote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavida","family":"Pachariyanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley Gibler","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirla","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2020.102393_bib0039","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ene.13622","article-title":"Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?","volume":"25","author":"Alari-Pahissa","year":"2018","journal-title":"Eur J Neurol"},{"issue":"24","key":"10.1016\/j.msard.2020.102393_bib0029","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.msard.2020.102393_bib0006","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1468-1331.2011.03650.x","article-title":"Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1\u00d715","volume":"19","author":"Baarnhielm","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2020.102393_bib0011","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.17119.1","article-title":"CD28 (null) CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection","volume":"8","author":"Bano","year":"2019","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.msard.2020.102393_bib0026","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102393_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2006.10.010","article-title":"The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys","volume":"182","author":"Brok","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.msard.2020.102393_bib0004","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","article-title":"HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis","volume":"2","author":"Brynedal","year":"2007","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.msard.2020.102393_bib0030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","article-title":"Epstein-Barr virus and disease activity in multiple sclerosis","volume":"76","author":"Buljevac","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.msard.2020.102393_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000496402","article-title":"Herpesviridae Seropositivity in Patients with Multiple Sclerosis: first Polish Study","volume":"80","author":"Czarnowska","year":"2018","journal-title":"Eur Neurol"},{"issue":"7109","key":"10.1016\/j.msard.2020.102393_bib0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.msard.2020.102393_bib0014","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.msard.2020.102393_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/472978","article-title":"Human Cytomegalovirus and Autoimmune Disease","volume":"2014","author":"Halenius","year":"2014","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.msard.2020.102393_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.msard.2020.102393_bib0005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1352458506073501","article-title":"Smoking is a risk factor for multiple sclerosis: a metanalysis","volume":"13","author":"Hawkes","year":"2007","journal-title":"Mult Scler"},{"issue":"7414","key":"10.1016\/j.msard.2020.102393_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0044","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2010.10.031","article-title":"Human cytomegalovirus immunity and immune evasion","volume":"157","author":"Jackson","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.msard.2020.102393_bib0045","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520907901","article-title":"Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors","author":"Jacobs","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102393_bib0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jneuroim.2017.04.004","article-title":"Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: a population-based study","volume":"309","author":"Karampoor","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"13","key":"10.1016\/j.msard.2020.102393_bib0038","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2020.102393_bib0032","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0041","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jinf.2019.10.017","article-title":"A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls","volume":"80","author":"Maple","year":"2020","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.msard.2020.102393_bib0043","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI200112516","article-title":"CD4+CD28- costimulation-independent T cells in multiple sclerosis","volume":"108","author":"Markovic-Plese","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.msard.2020.102393_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1352458515601215","article-title":"Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis","volume":"22","author":"Mart\u00ednez-Rodr\u00edguez","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2010.06.002","article-title":"Natural killer receptors distribution in multiple sclerosis: relation to clinical course and interferon-beta therapy","volume":"137","author":"Martinez-Rodriguez","year":"2010","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.msard.2020.102393_bib0018","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med."},{"issue":"19","key":"10.1016\/j.msard.2020.102393_bib0007","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"73","author":"Munger","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2020.102393_bib0036","doi-asserted-by":"crossref","first-page":"e36582","DOI":"10.5812\/jjm.36582","article-title":"Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: a Case-Control Study in Northern Iran","volume":"9","author":"Najafi","year":"2016","journal-title":"Jundishapur J Microbiol"},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.msard.2020.102393_bib0017","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s00415-013-6912-4","article-title":"Cytomegalovirus and multiple sclerosis risk","volume":"260","author":"Pakpoor","year":"2013","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.msard.2020.102393_bib0021","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0022","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0034","first-page":"263","article-title":"Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis","volume":"34","author":"Sanadgol","year":"2011","journal-title":"New Microbiol"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molmed.2014.11.002","article-title":"Cytomegalovirus: a culprit or protector in multiple sclerosis?","volume":"21","author":"Vanheusden","year":"2015","journal-title":"Trends Mol Med"},{"issue":"2","key":"10.1016\/j.msard.2020.102393_bib0028","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","article-title":"Association between clinical disease activity and Epstein-Barr virus reactivation in MS","volume":"55","author":"Wandinger","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102393_bib0024","unstructured":"Wells, G.A., .Shea, B., O'Connell, D., Peterson, J., Welch, V., & Losos, M. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp]."},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0016","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12974-020-01840-2","article-title":"Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis","volume":"17","author":"Zabalza","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2020.102393_bib0042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12974-020-01840-2","article-title":"Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis","volume":"17","author":"Zabalza","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0013","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bbrc.2013.12.122","article-title":"Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats","volume":"443","author":"Zheng","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.msard.2020.102393_bib0031","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1179\/016164106X98134","article-title":"Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients","volume":"28","author":"Zivadinov","year":"2006","journal-title":"Neurol Res"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:53:20Z","timestamp":1761900800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820304685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":45,"alternative-id":["S2211034820304685"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102393","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102393"}}